Single Limb Resistance Training in Patients With Chronic Obstructive Pulmonary Disease (COPD) (COPD)
Pulmonary Disease, Chronic Obstructive
About this trial
This is an interventional treatment trial for Pulmonary Disease, Chronic Obstructive focused on measuring Pulmonary Disease, Chronic Obstructive, Lung Diseases, Obstructive, Single Limb, Elastic Resistance, Resistance Training, Minor Muscle Mass, Local muscle training
Eligibility Criteria
Inclusion Criteria:
- Adults 40 years and above.
- Stable (no exacerbations within 4 weeks before start of baseline testing) moderate to very severe COPD, stage II-IV, according to GOLD criteria i.e. Forced expiratory volume in one second (FEV1)/ forced vital capacity (FVC) < 0.70, FEV1 < 80% predicted.
- Ex-smoker.
- Stable medical treatment (no changes < 4 weeks before start of baseline testing).
- Living less than 60 km from training facility.
Exclusion Criteria:
- Musculoskeletal, rheumatic, cardiac or neurological disorders that might affect the exercise performance in training and tests.
- Previous lung surgery.
- Acute exacerbations of COPD that require a change in pharmacological management within four weeks preceding the start of the intervention
- Long-term oxygen treatment.
- Participated in organized exercise training, > 2 times a week, within 6 months before start of intervention.
- Body mass index (BMI) < 18 kg/m2.
Sites / Locations
- Huddinge University Hospital
- Umeå University Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Control group
High-repetitive single limb training
The control group will receive standardized patient education four times, once every two weeks, during the eight week intervention period.
The experimental group will receive a high-repetitive single limb exercise regime, three times a week for two months. In addition, the exercise group will receive patient education at four occasions during the intervention period.